Nasal Polyps clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Sorry, not currently recruiting here
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
at UC Irvine
Last updated: